Orig Stone Biotech(Zhejiang) Co.,Ltd.
Orig Stone Biotech(Zhejiang) Co.,Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer | Castration-Resistant Prostate Cancer (CRPC) | Enrolling by invitation | Early phase 1 | 2026-05-22 | NCT07240857 |